Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin versus insulin pump for pancreatic beta-cell protection in newly diagnosed type 2 diabetes
ChiCTR-PPR-15007045Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Sep 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of saxagliptin and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Islet beta-cell function. Started Sep 2015; status: recruiting.
02
Drugs
saxagliptinhuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-PPR-15007045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PPR-15007045.